• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Ariad Pharmaceuticals

Ariad Pharmaceuticals

  1. All
  2. 3rd Party
  1. Takeda Announces FDA Accelerated Approval of ALUNBRIGTM (brigatinib)

    Takeda Announces FDA Accelerated Approval of ALUNBRIGTM (brigatinib)

  2. The Top-Performing Funds in 2011's Toughest Category

    These two small-value funds have followed different paths to success in a difficult year for the peer group.

©2017 Morningstar Advisor. All right reserved.